← Back to search

Nykode Therapeutics ASA

VACBF · OTC MARKETS

Research and Development in Biotechnology

ESG Scores

Overall ESG

6.4

Environmental

6.6

Social

3.6

Governance

5.9

Gender Diversity

Female Directors0.375%

Women in Workforce0.5589999999999999%

CEO GenderMale